Overview

Multicenter Pilot Phase III Clinical Trials of JDP-205 iv Injection for the Treatment of Acute Urticaria Associated With an Acute Allergic Reaction.

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

This is a multicenter, parallel group, randomized, double-blind pilot Phase III clinical study of JDP-205 injection, versus diphenhydramine injection, 50 mg/mL (Benadryl or generic equivalent), in approximately 36 patients with acute urticaria requiring treatment in Hospital Emergency Departments, Urgent Care Centers and Allergy Clinics.

Phase:

Phase 3

Details

Lead Sponsor:

JDP Therapeutics, Inc.

Treatments:

Diphenhydramine
Promethazine